Fig. 2From: Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-upChanges in blood pressure and heart rate, and the relationship with the change in albuminuria. AU albuminuria, DBP diastolic blood pressure, MAU microalbuminuria, OAU overt albuminuria, HR heart rate, M month, SBP systolic blood pressure. The values are mean ± SD or %Back to article page